Founding Director and Endowed Chair for Stem Cell Transplant and Immunotherapy, Inova, Fairfax, Virginia
Falls Church ,Virginia
Joined December 2014
- Tweets565
- Following83
- Followers193
- Likes1.2K
Stephen Medlin retweeted
Just out! New IMS/ IMWG Definition of High Risk Myeloma.
@JCO_ASCO #IMWG25
@Myeloma_Society @IMFmyeloma @NikhilMunshiMD @mvmateos @SagarLonialMD @szusmani @NoopurRajeMD
Stephen Medlin retweeted
CH and blood counts predicts MN risk - @beatalleukemia
Saint Kate Hotel, Milwaukee, WI @Froedtert – at Milwaukee, WI
Stephen Medlin retweeted
Please watch this if you are a doctor practicing in the US.
Things are far worse now with the ABIM. #MedTwitter #EndMOC
This 2016 video by Dr. Teirstein Pres of @InfoNbpas would B the BEST 15 mins of UR time today.
Just pls watch. Paul will appear on #HealthcareUnfiltered soon to discuss more & provide a path forward. @AaronGoodman33 @VincentRK @doctorwes CC @MorieGertz
youtube.com/watch?v=_fc3BQ-9…
Stephen Medlin retweeted
This 2016 video by Dr. Teirstein Pres of @InfoNbpas would B the BEST 15 mins of UR time today.
Just pls watch. Paul will appear on #HealthcareUnfiltered soon to discuss more & provide a path forward. @AaronGoodman33 @VincentRK @doctorwes CC @MorieGertz
youtube.com/watch?v=_fc3BQ-9…
Stephen Medlin retweeted
On ABIM MOC. Please read!!!
To maintain the trust of patients we need to test the testers who test doctors
@AaronGoodman33 @doctorwes @chadinabhan @DavidSteensma We must create a Board Exam to ensure that ABIM leaders are qualified Testers. Goal is to improve patient care.
1/
Stephen Medlin retweeted
ABIM must wake up to the realization that doctors carry a smart phone computer with them. We work in teams. We have colleagues who we can consult for rare disorders and when doubts arise
End MOC. It’s useless.
CME, maintenance of licensure & credentialing is enough.
Stephen Medlin retweeted
Whole-genome sequencing [WGS] of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides [Aug 2, 2012] Egan et al. @BloodJournal ashpublications.org/blood/ar… #mmsm #cagenome
Stephen Medlin retweeted
I want to hear from @ASH_hematology and @ASCO on what concrete things have been accomplished since your letters and surveys on ABIM MOC?
@AaronGoodman33 @chadinabhan #MedTwitter
I urge our professional societies including @ASH_hematology @ASCO to advocate for us on ABIM MOC.
We support our societies with our dues and participation. By 99:1 membership opposes ABIM MOC. We need your advocacy. #MedTwitter
Stephen Medlin retweeted
250 citations! --> Assoc of Clinical Factors & Recent Anti-Cancer Therapy w/ COVID-19 Severity among Patients with Cancer: Report from COVID-19 & Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer
Stephen Medlin retweeted
Convalescent Plasma for Covid-19–Induced ARDS [Jan 25, 2024] @jwsenefeld @DrJPHenderson @DrMJoyner @NEJM Letter DOI: 10.1056/NEJMc2313675 #COVID19CP #COVID19
Stephen Medlin retweeted
🎉Finally out🎉
Axicabtagene ciloleucel versus tisagenlecleucel for relapsed or refractory large B-cell lymphoma
The balance between improved efficacy, increased severe toxicity and resource utilization
Open access
@AnnaSureda5 #lymsm sciencedirect.com/science/ar…
Stephen Medlin retweeted
Editorial @FDAOncology @NEJM #mmsm
✅22 cases out of 27,000, 14 with data
✅T-cell lymphoma,T-cell large granular lymphocytosis,peripheral T-cell lymphoma,cutaneous T-cell lymphoma
🛑3 cases with genetic info,CAR transgene detected in malignant clone
➡️nejm.org/doi/full/10.1056/NE…
Stephen Medlin retweeted
#Myeloma Paper of the Day: Nice pre-clinical study shows bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth better than just targeting BCMA by enhancing macrophage phagocytic clearance of myeloma cells: pubmed.ncbi.nlm.nih.gov/3824….
Stephen Medlin retweeted
Genomic Classification and Individualized Prognosis in Multiple Myeloma [Jan 9, 2024] @FrancescoMaura4 et al. @DrOlaLandgren @JCO_ASCO ascopubs.org/doi/10.1200/JCO… #mmsm #PrecisionMedicine #IRMMa & Dr. Maura Thread:
xitter.cf/FrancescoMaura4/status…
Excited to see our new paper entitled "Genomic Classification and Individualized Prognosis in Multiple Myeloma" out on @JCO_ASCO! A fantastic collaboration between @SylvesterCancer, @univmiami, @MSKCancerCenter, @nyulangone, @MoffittNews, @HDMyeloma and many others!! #mmsm (1/x)
Stephen Medlin retweeted
Brilliant work. Exciting to see progress on the prognostic scoring system that addresses the weaknesses of the current models
Stephen Medlin retweeted
Real World Third COVID19 Vaccine Dosing and Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] @mtmdphd , Hallmeyer, @vrepublic , Liao, @mullane_michael @scmedlin , Copeland, @JimW9200 @JPCRR institutionalrepository.aah.… #COVID19nCancer #COVID19Vaccine #IDonc
